Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
Metal-organic framework nanoparticles induced non-apoptotic cell death: Construction, mechanisms, and cancer therapy
Shaoshi Ma1, Yingying Wei2,3, Yajie Li1
1Medical Imaging Department of Shanxi Medical University, Taiyuan, 030001, PR China.
Abstract:
Tumor resistance to apoptosis remains a significant obstacle in cancer therapy. In recent years, non-apoptotic cell death modalities (such as ferroptosis, pyroptosis, and lethal autophagy) have emerged as promising strategies to overcome this resistance. However, most non-apoptotic cell death inducing drugs suffer from poor targeting, low tumor enrichment efficiency, and systemic toxicity, which limit their clinical application. Metal-organic framework nanoparticles (MOF NPs), which are composed of metal ions and organic linkers, offer a compelling solution due to their tunable structures and high drug loading capacity. These features enable them to enhance therapeutic efficacy by either efficiently delivering non-apoptotic inducers or acting as direct triggers for non-apoptotic cell death. This review systematically introduces the molecular mechanisms of ferroptosis, autophagy, pyroptosis, cuproptosis, and disulfidptosis. MOF NPs have unique advantages in inducing these mechanisms. The design strategies of MOF NPs based on these mechanisms (such as material composition, surface functionalization and responsive release) are mainly summarized. The applications and efficacy of them in the targeted induction of non-apoptotic cell death are subsequently reviewed. Finally, the challenges facing this field, including biosafety, large-scale preparation, and clinical application, and future development directions are discussed and prospected.
Insights
Metal-organic framework nanoparticles (MOF NPs) offer a promising strategy to overcome cancer therapy resistance by inducing non-apoptotic cell death. MOF NPs enhance drug delivery and tumor targeting, addressing limitations of current treatments.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Tumor resistance to apoptosis is a major challenge in cancer treatment.
- Non-apoptotic cell death pathways (ferroptosis, pyroptosis, autophagy) show therapeutic potential.
- Existing non-apoptotic inducers face issues with targeting, tumor enrichment, and toxicity.
Purpose of the Study:
- To review the molecular mechanisms of various non-apoptotic cell death modalities.
- To explore the application of Metal-Organic Framework Nanoparticles (MOF NPs) in inducing non-apoptotic cell death.
- To summarize MOF NP design strategies and their efficacy in cancer therapy.
Main Methods:
- Systematic review of literature on non-apoptotic cell death mechanisms.
- Analysis of MOF NP properties relevant to drug delivery and cell death induction.
- Summary of MOF NP design strategies (composition, functionalization, release).
Main Results:
- MOF NPs demonstrate tunable structures and high drug loading capacity.
- MOF NPs can efficiently deliver non-apoptotic inducers or directly trigger cell death.
- MOF NPs show promise in targeted induction of ferroptosis, pyroptosis, autophagy, cuproptosis, and disulfidptosis.
Conclusions:
- MOF NPs present a viable strategy to overcome therapeutic resistance by inducing non-apoptotic cell death.
- Design strategies for MOF NPs can be tailored to specific non-apoptotic pathways.
- Further research is needed to address challenges in biosafety, scalability, and clinical translation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Apoptosis
Cellular Injury V: Apoptosis and Autophagy

